CV Sciences, Inc. to Webcast Live at VirtualInvestorConferences.com June 1, 2017

May 30, 2017

CV Sciences, Inc. Appoints Dr. Stephen M. Schmitz to its Board of Directors

May 16, 2017

CV Sciences, Inc. Highlights WHO's World No Tobacco Day, May 31, 2017

May 8, 2017

CV Sciences, Inc. Announces Pre-IND Meeting Date with FDA

May 2, 2017

CV Sciences, Inc. Applauds U.S. Department of Defense Smokeless Tobacco Cessation Campaign

Mar 22, 2017

CV Sciences, Inc. to Exhibit its Industry Dominating Hemp-derived CBD Brand, PlusCBD Oil(TM), at Natural Products Expo West in Anaheim, CA - March 9-12, 2017

Feb 28, 2017

CV Sciences, Inc. to Present at NobleCon13 Annual Investor Conference

Jan 25, 2017

CV Sciences, Inc. to Present at 9th Annual Biotech Showcase

Dec 22, 2016

CV Sciences, Inc. Highlights Major League Baseball (MLB) Decision to Prohibit All New Players From Using Smokeless Tobacco

Dec 20, 2016

CV Sciences, Inc. Provides Details for Webcast Discussing Its CBD-Based Drug Development Program on November 10, 2016

Nov 3, 2016